sFRP-2 activated the Wnt pathway and promoted renal cancer growth [111] whereas sFRP-3 expression induced the MMP-3 and ANGPT1 genes in renal cancer and thus contributed to the invasive capability of RCC [112]. The gene discussed is FRZB; the disease is renal carcinoma.